LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Kataria, Saurabh"
  2. AU=Wang Xia AU=Wang Xia
  3. AU="Tonnesen, Morten"
  4. AU="Ebrahimi-Fakhari, Darius"
  5. AU="Kalinich, Chaney C"
  6. AU="O'Neal, David N"
  7. AU="Bennett, Matthew R"
  8. AU="Chagas, Mariana W"

Suchergebnis

Treffer 1 - 10 von insgesamt 62

Suchoptionen

  1. Artikel: Multiple Sclerosis Relapse Following COVID-19 Vaccination: A Case Report and Literature Review.

    Kataria, Saurabh / Rogers, Sylvette / Bilal, Usama / Baktashi, Haisum / Singh, Romil

    Cureus

    2022  Band 14, Heft 1, Seite(n) e21374

    Abstract: Mass vaccination against coronavirus disease 19 (COVID-19) has effectively controlled the pandemic and has been remarkably effective and safe. Reports of a few adverse events have been reported after post-marketing surveillance. We present a rare case of ...

    Abstract Mass vaccination against coronavirus disease 19 (COVID-19) has effectively controlled the pandemic and has been remarkably effective and safe. Reports of a few adverse events have been reported after post-marketing surveillance. We present a rare case of multiple sclerosis (MS) relapse in a female who presented with fatigue, involuntary eye movements, and numbness; autoimmunity following the COVID-19 vaccine has also been described. She was diagnosed with MS six years back and was in remission. She received her COVID-19 vaccine 18 days ago. Her clinical and radiological features confirmed the MS relapse. Her serology for COVID-19 immunoglobulin G (IgG) and IgM was positive, and she was managed with intravenous methylprednisolone and symptomatic management. Our case provides a possible association of vaccine-associated MS relapse; however, more evidence is warranted from future studies.
    Sprache Englisch
    Erscheinungsdatum 2022-01-18
    Erscheinungsland United States
    Dokumenttyp Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.21374
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Buch ; Online: AdvEst

    Joshi, Sonal / Kataria, Saurabh / Villalba, Jesus / Dehak, Najim

    Adversarial Perturbation Estimation to Classify and Detect Adversarial Attacks against Speaker Identification

    2022  

    Abstract: Adversarial attacks pose a severe security threat to the state-of-the-art speaker identification systems, thereby making it vital to propose countermeasures against them. Building on our previous work that used representation learning to classify and ... ...

    Abstract Adversarial attacks pose a severe security threat to the state-of-the-art speaker identification systems, thereby making it vital to propose countermeasures against them. Building on our previous work that used representation learning to classify and detect adversarial attacks, we propose an improvement to it using AdvEst, a method to estimate adversarial perturbation. First, we prove our claim that training the representation learning network using adversarial perturbations as opposed to adversarial examples (consisting of the combination of clean signal and adversarial perturbation) is beneficial because it eliminates nuisance information. At inference time, we use a time-domain denoiser to estimate the adversarial perturbations from adversarial examples. Using our improved representation learning approach to obtain attack embeddings (signatures), we evaluate their performance for three applications: known attack classification, attack verification, and unknown attack detection. We show that common attacks in the literature (Fast Gradient Sign Method (FGSM), Projected Gradient Descent (PGD), Carlini-Wagner (CW) with different Lp threat models) can be classified with an accuracy of ~96%. We also detect unknown attacks with an equal error rate (EER) of ~9%, which is absolute improvement of ~12% from our previous work.

    Comment: Submitted to InterSpeech 2022
    Schlagwörter Electrical Engineering and Systems Science - Audio and Speech Processing ; Computer Science - Cryptography and Security ; Computer Science - Sound
    Thema/Rubrik (Code) 006
    Erscheinungsdatum 2022-04-08
    Erscheinungsland us
    Dokumenttyp Buch ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  3. Artikel: A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies

    Kataria, Saurabh Tandon Medha Melnic Violina Sriwastava Shitiz

    eNeurologicalSci

    Abstract: Background: In view of the emerging coronavirus pandemic, the demand for knowledge about the impact of SARS-CoV-2 on people with Multiple Sclerosis (MS) continues to grow Patients receiving disease modifying therapy (DMT) for MS have a higher background ... ...

    Abstract Background: In view of the emerging coronavirus pandemic, the demand for knowledge about the impact of SARS-CoV-2 on people with Multiple Sclerosis (MS) continues to grow Patients receiving disease modifying therapy (DMT) for MS have a higher background risk of infection-related health care utilization when compared to the general population Therefore, there is a need of evidence-based recommendations to reduce the risk of infection and also managing MS patients with SARS-CoV-2 Case Description: A case series of three patients with history of Multiple Sclerosis (MS) on DMTs presented with worsening MS symptoms likely pseudo exacerbation who were diagnosed with COVID-19 Discussion: An extensive review of 7 articles was performed, in addition to a brief review on DMTs use in MS patients with COVID-19 In our cases, all patients were on DMT and severe course of disease was noted in 2 cases No fatality was observed Conclusions: This review provides a base on the clinical characteristics, outcomes and the roles of DMTs in MS patients suffering from n-Cov2 Physicians need to be vigilant about considering COVID-19 infection related relapse in the MS patients, especially in this COVID-19 pandemic era and look for pseudo-exacerbation As most cases are found to have mild course and full recovery on DMTs, further research is needed to formulate evidence-based guidelines This review will particularly be helpful for the researchers and registries to collect future data on MS and COVID-19
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #898813
    Datenquelle COVID19

    Kategorien

  4. Artikel ; Online: A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies.

    Kataria, Saurabh / Tandon, Medha / Melnic, Violina / Sriwastava, Shitiz

    eNeurologicalSci

    2020  Band 21, Seite(n) 100287

    Abstract: Background: In view of the emerging coronavirus pandemic, the demand for knowledge about the impact of SARS-CoV-2 on people with Multiple Sclerosis (MS) continues to grow. Patients receiving disease modifying therapy (DMT) for MS have a higher ... ...

    Abstract Background: In view of the emerging coronavirus pandemic, the demand for knowledge about the impact of SARS-CoV-2 on people with Multiple Sclerosis (MS) continues to grow. Patients receiving disease modifying therapy (DMT) for MS have a higher background risk of infection-related health care utilization when compared to the general population. Therefore, there is a need of evidence-based recommendations to reduce the risk of infection and also managing MS patients with SARS-CoV-2.
    Case description: We present three patients with history of Multiple Sclerosis (MS) on DMTs presenting with worsening MS symptoms likely pseudo exacerbation who were diagnosed with COVID-19.
    Discussion: An extensive review of 7 articles was performed, in addition to a brief review on DMTs use in MS patients with COVID-19. In our cases, all patients were on DMT and severe course of disease was noted in 2 cases. No fatality was observed.
    Conclusions: This review provides a base on the clinical characteristics, outcomes and the roles of DMTs in MS patients suffering from n-cov-2. Physicians need to be vigilant about considering COVID-19 infection related relapse in the MS patients, especially in this COVID-19 pandemic era and look for pseudo-exacerbation. As most cases are found to have mild course and full recovery on DMTs, further research is needed to formulate evidence-based guidelines. This review will particularly be helpful for the researchers and registries to collect future data on MS and COVID-19.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-11-02
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 2838045-9
    ISSN 2405-6502 ; 2405-6502
    ISSN (online) 2405-6502
    ISSN 2405-6502
    DOI 10.1016/j.ensci.2020.100287
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Immune Thrombocytopenia and Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Case Report.

    Kataria, Saurabh / Reza, Rezaur Rahman / Agboola, Adesola A / Mohamed, Khalid H / Mohamed, Alaa S / Zahid, Nimra / Haseeb, Muhammad / Nasir, Hira

    Cureus

    2023  Band 15, Heft 1, Seite(n) e34272

    Abstract: Mass vaccination against coronavirus disease 2019 (COVID-19) has been safe and effective. The ongoing emergence of vaccine-induced complications has challenged the public trust in vaccination programs and, though uncommon, can lead to significant ... ...

    Abstract Mass vaccination against coronavirus disease 2019 (COVID-19) has been safe and effective. The ongoing emergence of vaccine-induced complications has challenged the public trust in vaccination programs and, though uncommon, can lead to significant morbidity and mortality. Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare and fatal complication of the COVID-19 vaccine. We present a rare case of VITT in a young female who presented with worsening headache, body rash with deteriorating neurological deficit after 12 days of the second dose of the ChAdOx1 COVID-19 vaccine. Initial blood tests showed thrombocytopenia with deranged clotting time and D-dimer levels. Her computed tomography venogram showed thrombosis in the left transverse sinus, and she was diagnosed with a provisional diagnosis of VITT. She initially managed with dexamethasone, intravenous immunoglobulins, and apixaban to reverse the autoimmune process. Our case highlights the clinical course, diagnosis, and management of VITT, which will assist physicians in the timely recognition and adequate management of VITT.
    Sprache Englisch
    Erscheinungsdatum 2023-01-27
    Erscheinungsland United States
    Dokumenttyp Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.34272
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Buch ; Online: Joint domain adaptation and speech bandwidth extension using time-domain GANs for speaker verification

    Kataria, Saurabh / Villalba, Jesús / Moro-Velázquez, Laureano / Dehak, Najim

    2022  

    Abstract: Speech systems developed for a particular choice of acoustic domain and sampling frequency do not translate easily to others. The usual practice is to learn domain adaptation and bandwidth extension models independently. Contrary to this, we propose to ... ...

    Abstract Speech systems developed for a particular choice of acoustic domain and sampling frequency do not translate easily to others. The usual practice is to learn domain adaptation and bandwidth extension models independently. Contrary to this, we propose to learn both tasks together. Particularly, we learn to map narrowband conversational telephone speech to wideband microphone speech. We developed parallel and non-parallel learning solutions which utilize both paired and unpaired data. First, we first discuss joint and disjoint training of multiple generative models for our tasks. Then, we propose a two-stage learning solution where we use a pre-trained domain adaptation system for pre-processing in bandwidth extension training. We evaluated our schemes on a Speaker Verification downstream task. We used the JHU-MIT experimental setup for NIST SRE21, which comprises SRE16, SRE-CTS Superset and SRE21. Our results provide the first evidence that learning both tasks is better than learning just one. On SRE16, our best system achieves 22% relative improvement in Equal Error Rate w.r.t. a direct learning baseline and 8% w.r.t. a strong bandwidth expansion system.

    Comment: submitted to Interspeech 2022
    Schlagwörter Electrical Engineering and Systems Science - Audio and Speech Processing ; Computer Science - Sound
    Thema/Rubrik (Code) 004 ; 006
    Erscheinungsdatum 2022-03-30
    Erscheinungsland us
    Dokumenttyp Buch ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Buch ; Online: Self-FiLM

    Kataria, Saurabh / Villalba, Jesús / Moro-Velázquez, Laureano / Thebaud, Thomas / Dehak, Najim

    Conditioning GANs with self-supervised representations for bandwidth extension based speaker recognition

    2023  

    Abstract: Speech super-resolution/Bandwidth Extension (BWE) can improve downstream tasks like Automatic Speaker Verification (ASV). We introduce a simple novel technique called Self-FiLM to inject self-supervision into existing BWE models via Feature-wise Linear ... ...

    Abstract Speech super-resolution/Bandwidth Extension (BWE) can improve downstream tasks like Automatic Speaker Verification (ASV). We introduce a simple novel technique called Self-FiLM to inject self-supervision into existing BWE models via Feature-wise Linear Modulation. We hypothesize that such information captures domain/environment information, which can give zero-shot generalization. Self-FiLM Conditional GAN (CGAN) gives 18% relative improvement in Equal Error Rate and 8.5% in minimum Decision Cost Function using state-of-the-art ASV system on SRE21 test. We further by 1) deep feature loss from time-domain models and 2) re-training of data2vec 2.0 models on naturalistic wideband (VoxCeleb) and telephone data (SRE Superset etc.). Lastly, we integrate self-supervision with CycleGAN to present a completely unsupervised solution that matches the semi-supervised performance.

    Comment: Under review
    Schlagwörter Electrical Engineering and Systems Science - Audio and Speech Processing
    Thema/Rubrik (Code) 006
    Erscheinungsdatum 2023-03-07
    Erscheinungsland us
    Dokumenttyp Buch ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  8. Artikel: A Case Report on Charcot-Marie-Tooth Disease with a Novel Periaxin Gene Mutation.

    Datta, Sorabh / Kataria, Saurabh / Govindarajan, Raghav

    Cureus

    2019  Band 11, Heft 7, Seite(n) e5111

    Abstract: Charcot-Marie-Tooth (CMT) disease is one of the most common primary hereditary neuropathies causing peripheral neuropathies. More than 60 different gene mutations are causing this disease. ... ...

    Abstract Charcot-Marie-Tooth (CMT) disease is one of the most common primary hereditary neuropathies causing peripheral neuropathies. More than 60 different gene mutations are causing this disease. The
    Sprache Englisch
    Erscheinungsdatum 2019-07-09
    Erscheinungsland United States
    Dokumenttyp Case Reports
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.5111
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review.

    Tolson, Jack K / Menuet, Robert L / Ly, Gianni H / Chanes, Benjamin A / Bryan, Elizabeth A / Kataria, Saurabh / Kim, Julian / Ahmadzadeh, Shahab / Shekoohi, Sahar / Kaye, Alan D

    Expert opinion on emerging drugs

    2024  , Seite(n) 1–10

    Abstract: Introduction: Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower back pain. Currently, accepted treatments for ...

    Abstract Introduction: Chronic lower back pain is a leading cause of disability and healthcare spending worldwide. Discogenic pain, pain originating from the intervertebral disk, is a common etiology of chronic lower back pain. Currently, accepted treatments for chronic discogenic pain focus only on the management of symptoms, such as pain. There are no approved treatments that stop or reverse degenerating intervertebral discs. Biologic therapies promoting disc regeneration have been developed to expand treatment options. VIADISC™ NP, is a viable disc allograft supplementation that, in a recent trial, demonstrated a significant reduction in pain and increased function in patients suffering from symptomatic degenerative disc disease.
    Areas covered: This manuscript summarizes the epidemiology and etiology of low back pain, the pathophysiology of degenerative disc disease, current treatments, and a need for newer therapies. The rationale behind intradiscal biologics for the treatment of symptomatic degenerative disc disease is also discussed.
    Expert opinion: Characterization of the biology leading to disc degeneration has allowed for the development of intradiscal biologics. They may soon be capable of preventing and reversing disc degeneration. Clinical trials have shown promise, but further research into efficacy and safety is needed before these therapies are widely employed.
    Sprache Englisch
    Erscheinungsdatum 2024-04-15
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2061369-6
    ISSN 1744-7623 ; 1472-8214
    ISSN (online) 1744-7623
    ISSN 1472-8214
    DOI 10.1080/14728214.2024.2339912
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Peripheral Nerve Stimulation in Postoperative Analgesia: A Narrative Review.

    Kaye, Alan D / Plaisance, Taylor R / Smith, Summer A / Ragland, Amanda R / Alfred, Michael J / Nguyen, Catherine G / Chami, Azem A / Kataria, Saurabh / Dufrene, Kylie / Shekoohi, Sahar / Robinson, Christopher L

    Current pain and headache reports

    2024  

    Abstract: Purpose of review: Recent research has shown the effectiveness of peripheral nerve stimulators (PNS) in managing chronic pain conditions. Ongoing studies aim to explore its potential application in treating acute postoperative pain states. The purpose ... ...

    Abstract Purpose of review: Recent research has shown the effectiveness of peripheral nerve stimulators (PNS) in managing chronic pain conditions. Ongoing studies aim to explore its potential application in treating acute postoperative pain states. The purpose of this systematic review is to assess the role of PNS in providing relief for postoperative pain.
    Recent findings: Clinical studies investigating the use of peripheral nerve stimulators (PNS) for analgesia following various surgeries, such as total knee arthroplasty, anterior cruciate ligament repair, ankle arthroplasty, rotator cuff repair, hallux valgus correction, and extremity amputation, have shown promising results. Lead placement locations include the brachial plexus, sciatic, femoral, tibial, genicular, perineal, sural, radial, median, and ulnar nerves. These studies consistently report clinically significant reductions in pain scores, and some even indicate a decrease in opioid consumption following PNS for postoperative pain. PNS involves the subcutaneous placement of electrode leads to target peripheral nerve(s) followed by delivery of an electric current via an external pulse generator. While the precise mechanism is not fully understood, the theory posits that PNS modulates electrical stimulation, hindering the signaling of nociceptive pain. PNS presents itself as an alternative to opioid therapy, holding promise to address the opioid epidemic by offering a nonpharmacologic approach for both acute and chronic pain states.
    Sprache Englisch
    Erscheinungsdatum 2024-04-20
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2055062-5
    ISSN 1534-3081 ; 1531-3433
    ISSN (online) 1534-3081
    ISSN 1531-3433
    DOI 10.1007/s11916-024-01257-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang